霜打了的葡萄
Lv51
920 积分
2023-04-10 加入
-
Anti-CD19 antibodies inhibit the function of the P-gp pump in multidrug-resistant B lymphoma cells
2小时前
已关闭
-
Extremely potent, rapid and costimulation‐independent cytotoxic T‐cell response against lymphoma cells catalyzed by a single‐chain bispecific antibody
6小时前
已完结
-
Antiangiogenic–immune-checkpoint inhibitor combinations: lessons from phase III clinical trials
4天前
已完结
-
MM-087 Early, Deep, and Durable Responses, and Low Rates of Cytokine Release Syndrome With REGN5458, a BCMAxCD3 Bispecific Antibody, in a Phase 1/2 First-In-Human Study in Patients With Relapsed/Refractory Multiple Myeloma
5天前
已完结
-
Transmembrane signals generated through MHC class II, CD19, CD20, CD39, and CD40 antigens induce LFA-1-dependent and independent adhesion in human B cells through a tyrosine kinase-dependent pathway
7天前
已关闭
-
CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation
8天前
已完结
-
Clinical and translational advances in ovarian cancer therapy
9天前
已完结
-
Raludotatug deruxtecan monotherapy among patients with previously treated ovarian cancer: Subgroup analysis of a first-in-human phase I study
21天前
已完结
-
CD27-Armored BCMA CAR T Cell Therapy (CBG-002) for Relapsed and Refractory Multiple Myeloma: A Phase I Clinical Trial
23天前
已完结
-
A Phase 1 Study of a CDH6-Targeting Antibody-Drug Conjugate in Patients with Advanced Solid Tumors with Evaluation of Inflammatory and Neurological Adverse Events
1个月前
已完结